Related Experiment Video
Updated: Jul 11, 2026

09:09
Pancreatic Islet Embedding for Paraffin Sections
Published on: June 29, 2018
In vivo and in vitro techniques to study pancreas development and islet cell function
Bertrand Duvillié1, Mylène Heinis, Volodymyr Stetsyuk
1INSERM U845, Necker Hospital, Faculty of Medicine, University Paris-Descartes, Paris , France.
Endocrine Development
|October 10, 2007
Summary
Fibroblast growth factor 10 (FGF10) is crucial for pancreas development. FGF10 promotes beta-cell mass by enhancing precursor cell proliferation and extending endocrine differentiation markers.
Area of Science:
- Developmental Biology
- Endocrinology
- Cell Biology
Background:
- Pancreas development is critical for human health, with beta-cell regeneration being a key therapeutic goal.
- Mesenchymal inductive signals are essential for precursor cell proliferation during pancreas development.
- Fibroblast growth factors (FGFs) are implicated in various developmental processes, including pancreatic organogenesis.
Purpose of the Study:
- To review and elucidate the specific roles of fibroblast growth factors (FGFs), particularly FGF10, in pancreas development.
- To investigate the precise mechanisms by which FGF10 influences beta-cell mass and differentiation.
- To compare findings from various in vivo and in vitro experimental systems.
Main Methods:
- Review of existing literature on FGFs in pancreas development.
- Analysis of data from FGF10 knockout mouse models.
- In vitro studies using pancreas explants cultured at an air-liquid interface.
- Examination of beta-cell differentiation markers, including Ngn3 expression.
Main Results:
- FGF10 is essential for pancreas development and precursor cell proliferation.
- FGF10 administration increases beta-cell mass by promoting early precursor proliferation.
- FGF10 extends the expression window of the endocrine precursor marker Ngn3, facilitating differentiation.
Conclusions:
- FGF10 plays a significant positive regulatory role in beta-cell mass expansion during pancreas development.
- The findings highlight FGF10 as a potential target for therapeutic strategies aimed at beta-cell regeneration.
- Further research into other FGF family members in pancreas development is warranted.

